FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

Taro Pharmaceuticals U.S.A. Clobetasol Propionate Cream Recall

Clobetasol Propionate Cream USP, 0

Taro Pharmaceuticals U.S.A., Inc. · Hawthorne, NY

Risk level
Class III
Reported by FDA
Aug 19, 2020
Recall ID
D-1496-2020
Check your lot numberHow we source this data

Summary

Taro Pharmaceuticals U.S.A. recalled Clobetasol Propionate Cream starting Jul 20, 2020. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-1496-2020 on Aug 19, 2020. Reason: Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity. Status: Terminated.

Why it was recalled

Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.

Product description

Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.

Lot numbers, UPCs & expiration codes

a) AB28353, Exp 12/31/2021; b) AB40178, Exp 12/31/2021

Where it was sold

Nationwide in the U.S.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1496-2020
Classification
Class III
Status
Terminated
Recall initiated
Jul 20, 2020
FDA report date
Aug 19, 2020
Quantity
7632 tubes
Recall type
Voluntary: Firm initiated
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.

Original FDA data

Every field from FDA enforcement report D-1496-2020, exactly as published.

Show all FDA fields
City
Hawthorne
State
NY
Status
Terminated
Country
United States
Event ID
86101
Address
3 Skyline Dr
Code information
a) AB28353, Exp 12/31/2021; b) AB40178, Exp 12/31/2021
Postal code
10532-2174
Report date
Aug 19, 2020
Product type
Drugs
Recall number
D-1496-2020
Classification
Class III
Recalling firm
Taro Pharmaceuticals U.S.A., Inc.
Product quantity
7632 tubes
Termination date
Jun 20, 2023
Reason for recall
Failed Content Uniformity: bulk lot used to make these two lots was found to have failed content uniformity.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Clobetasol Propionate Cream USP, 0.05%, a) 15 g tube, NDC: 60429-902-15; b) 45 g tube, NDC: 60429-902-45, Rx Only, For External Use Only, Not for Ophthalmic Use, Mfd by: Taro Pharmaceuticals Inc. Brampton, Ontario, Canada L6T 1C1, Marketed by: Golden State Medical Supply, Inc. Camarillo, CA 93012.
Distribution pattern
Nationwide in the U.S.
Recall initiation date
Jul 20, 2020
Initial firm notification
Letter
Center classification date
Aug 12, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1496-2020, published Aug 19, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls